{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T13:22:08Z","timestamp":1781184128798,"version":"3.54.1"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,4,6]],"date-time":"2025-04-06T00:00:00Z","timestamp":1743897600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,6]],"date-time":"2025-04-06T00:00:00Z","timestamp":1743897600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82173792"],"award-info":[{"award-number":["82173792"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"publisher","award":["LYY22H310009"],"award-info":[{"award-number":["LYY22H310009"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Hospital Pharmacy Scientific Research Funding Project of Zhejiang Pharmaceutical Association","award":["2020ZYY10"],"award-info":[{"award-number":["2020ZYY10"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Toxicol"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1007\/s00204-025-04030-2","type":"journal-article","created":{"date-parts":[[2025,4,6]],"date-time":"2025-04-06T07:02:21Z","timestamp":1743922941000},"page":"2639-2653","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Dihydromyricetin restores lysosomal function in Schwann cells to alleviate bortezomib-induced peripheral neuropathy via ERK\/TFEB signaling"],"prefix":"10.1007","volume":"99","author":[{"given":"Xiaoliang","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingxian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinhang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huajing","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayu","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuyun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuhua","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziqi","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangnan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8502-7290","authenticated-orcid":false,"given":"Jiaying","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,6]]},"reference":[{"key":"4030_CR1","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1182\/blood-2008-04-149385","volume":"112","author":"AA Argyriou","year":"2008","unstructured":"Argyriou AA, Iconomou G, Kalofonos HP (2008) Bortezomib-induced peripheral neuropathy in multiple myeloma: a comprehensive review of the literature. Blood 112:1593\u20131599. https:\/\/doi.org\/10.1182\/blood-2008-04-149385","journal-title":"Blood"},{"key":"4030_CR2","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1007\/s00204-014-1316-5","volume":"88","author":"AA Argyriou","year":"2014","unstructured":"Argyriou AA, Cavaletti G, Bruna J et al (2014) Bortezomib-induced peripheral neurotoxicity: an update. Arch Toxicol 88:1669\u20131679. https:\/\/doi.org\/10.1007\/s00204-014-1316-5","journal-title":"Arch Toxicol"},{"key":"4030_CR3","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/j.expneurol.2010.02.006","volume":"223","author":"J Bruna","year":"2010","unstructured":"Bruna J, Udina E, Al\u00e9 A et al (2010) Neurophysiological, histological and immunohistochemical characterization of bortezomib-induced neuropathy in mice. Exp Neurol 223:599\u2013608. https:\/\/doi.org\/10.1016\/j.expneurol.2010.02.006","journal-title":"Exp Neurol"},{"key":"4030_CR4","doi-asserted-by":"publisher","first-page":"410","DOI":"10.4161\/auto.22866","volume":"9","author":"M Cea","year":"2013","unstructured":"Cea M, Cagnetta A, Patrone F et al (2013) Intracellular NAD(+) depletion induces autophagic death in multiple myeloma cells. Autophagy 9:410\u2013412. https:\/\/doi.org\/10.4161\/auto.22866","journal-title":"Autophagy"},{"key":"4030_CR5","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1111\/j.1529-8027.2008.00193.x","volume":"13","author":"V Chaudhry","year":"2008","unstructured":"Chaudhry V, Cornblath DR, Polydefkis M et al (2008) Characteristics of bortezomib- and thalidomide-induced peripheral neuropathy. J Peripher Nerv Syst JPNS 13:275\u2013282. https:\/\/doi.org\/10.1111\/j.1529-8027.2008.00193.x","journal-title":"J Peripher Nerv Syst JPNS"},{"key":"4030_CR6","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.phrs.2015.05.009","volume":"99","author":"S Chen","year":"2015","unstructured":"Chen S, Zhao X, Wan J et al (2015) Dihydromyricetin improves glucose and lipid metabolism and exerts anti-inflammatory effects in nonalcoholic fatty liver disease: a randomized controlled trial. Pharmacol Res 99:74\u201381. https:\/\/doi.org\/10.1016\/j.phrs.2015.05.009","journal-title":"Pharmacol Res"},{"key":"4030_CR7","doi-asserted-by":"publisher","first-page":"6692579","DOI":"10.1155\/2021\/6692579","volume":"2021","author":"L Chen","year":"2021","unstructured":"Chen L, Shi M, Lv C et al (2021a) Dihydromyricetin acts as a potential redox balance mediator in cancer chemoprevention. Mediators Inflamm 2021:6692579. https:\/\/doi.org\/10.1155\/2021\/6692579","journal-title":"Mediators Inflamm"},{"key":"4030_CR8","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1038\/s41418-020-00646-2","volume":"28","author":"X Chen","year":"2021","unstructured":"Chen X, Guan Y, Zhang Y et al (2021b) Programmed cell death 4 modulates lysosomal function by inhibiting TFEB translation. Cell Death Differ 28:1237\u20131250. https:\/\/doi.org\/10.1038\/s41418-020-00646-2","journal-title":"Cell Death Differ"},{"key":"4030_CR9","doi-asserted-by":"publisher","first-page":"5752","DOI":"10.1182\/bloodadvances.2022008241","volume":"7","author":"J Chen","year":"2023","unstructured":"Chen J, Cao W, Huang X et al (2023) TRIM21 enhances bortezomib sensitivity in multiple myeloma by halting prosurvival autophagy. Blood Adv 7:5752\u20135770. https:\/\/doi.org\/10.1182\/bloodadvances.2022008241","journal-title":"Blood Adv"},{"key":"4030_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2021.153642","volume":"90","author":"C-H Chou","year":"2021","unstructured":"Chou C-H, Lu K-H, Yang J-S et al (2021) Dihydromyricetin suppresses cell metastasis in human osteosarcoma through SP-1- and NF-\u03baB-modulated urokinase plasminogen activator inhibition. Phytomedicine 90:153642. https:\/\/doi.org\/10.1016\/j.phymed.2021.153642","journal-title":"Phytomedicine"},{"key":"4030_CR11","doi-asserted-by":"publisher","first-page":"4770","DOI":"10.1038\/s41380-022-01713-5","volume":"27","author":"YS Chun","year":"2022","unstructured":"Chun YS, Kim M-Y, Lee S-Y et al (2022) MEK1\/2 inhibition rescues neurodegeneration by TFEB-mediated activation of autophagic lysosomal function in a model of Alzheimer\u2019s Disease. Mol Psychiatry 27:4770\u20134780. https:\/\/doi.org\/10.1038\/s41380-022-01713-5","journal-title":"Mol Psychiatry"},{"key":"4030_CR12","doi-asserted-by":"publisher","first-page":"9758","DOI":"10.3892\/mmr.2017.7802","volume":"16","author":"K-J Fan","year":"2017","unstructured":"Fan K-J, Yang B, Liu Y et al (2017) Inhibition of human lung cancer proliferation through targeting stromal fibroblasts by dihydromyricetin. Mol Med Rep 16:9758\u20139762. https:\/\/doi.org\/10.3892\/mmr.2017.7802","journal-title":"Mol Med Rep"},{"key":"4030_CR13","doi-asserted-by":"publisher","DOI":"10.1111\/1440-1681.13833","volume":"51","author":"J Fang","year":"2024","unstructured":"Fang J, Lou S, Zhou X et al (2024) Dihydromyricetin reverses capecitabine-induced peripheral myelin dysfunction through modulation of oxidative stress. Clin Exp Pharmacol Physiol 51:e13833. https:\/\/doi.org\/10.1111\/1440-1681.13833","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"4030_CR14","doi-asserted-by":"publisher","first-page":"14619","DOI":"10.1038\/s41598-019-51124-w","volume":"9","author":"H Ge","year":"2019","unstructured":"Ge H, Guan S, Shen Y et al (2019) Dihydromyricetin affects BDNF levels in the nervous system in rats with comorbid diabetic neuropathic pain and depression. Sci Rep 9:14619. https:\/\/doi.org\/10.1038\/s41598-019-51124-w","journal-title":"Sci Rep"},{"key":"4030_CR15","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1007\/s11302-020-09752-9","volume":"16","author":"H Ge","year":"2020","unstructured":"Ge H, Sun M, Wei X et al (2020) Protective effects of dihydromyricetin on primary hippocampal astrocytes from cytotoxicity induced by comorbid diabetic neuropathic pain and depression. Purinergic Signal 16:585\u2013599. https:\/\/doi.org\/10.1007\/s11302-020-09752-9","journal-title":"Purinergic Signal"},{"key":"4030_CR16","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1083\/jcb.201503019","volume":"210","author":"JA Gomez-Sanchez","year":"2015","unstructured":"Gomez-Sanchez JA, Carty L, Iruarrizaga-Lejarreta M et al (2015) Schwann cell autophagy, myelinophagy, initiates myelin clearance from injured nerves. J Cell Biol 210:153\u2013168. https:\/\/doi.org\/10.1083\/jcb.201503019","journal-title":"J Cell Biol"},{"key":"4030_CR17","doi-asserted-by":"publisher","first-page":"770","DOI":"10.3389\/fpsyt.2019.00770","volume":"10","author":"S Guan","year":"2019","unstructured":"Guan S, Shen Y, Ge H et al (2019) Dihydromyricetin alleviates diabetic neuropathic pain and depression comorbidity symptoms by inhibiting P2X7 receptor. Front Psychiatry 10:770. https:\/\/doi.org\/10.3389\/fpsyt.2019.00770","journal-title":"Front Psychiatry"},{"key":"4030_CR18","doi-asserted-by":"publisher","first-page":"15106","DOI":"10.3390\/ijms232315106","volume":"23","author":"M-C Hsin","year":"2022","unstructured":"Hsin M-C, Hsiao Y-H, Chen P-N et al (2022) Dihydromyricetin inhibited migration and invasion by reducing S100A4 expression through ERK1\/2\/\u03b2-catenin pathway in human cervical cancer cell lines. Int J Mol Sci 23:15106. https:\/\/doi.org\/10.3390\/ijms232315106","journal-title":"Int J Mol Sci"},{"key":"4030_CR19","doi-asserted-by":"publisher","first-page":"3730","DOI":"10.3390\/cells11233730","volume":"11","author":"J Huang","year":"2022","unstructured":"Huang J, Chen B, Wang H et al (2022a) Dihydromyricetin attenuates depressive-like behaviors in mice by inhibiting the AGE-RAGE signaling pathway. Cells 11:3730. https:\/\/doi.org\/10.3390\/cells11233730","journal-title":"Cells"},{"key":"4030_CR20","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/s41419-022-04629-8","volume":"13","author":"X Huang","year":"2022","unstructured":"Huang X, Cao W, Yao S et al (2022b) NEDD4L binds the proteasome and promotes autophagy and bortezomib sensitivity in multiple myeloma. Cell Death Dis 13:197. https:\/\/doi.org\/10.1038\/s41419-022-04629-8","journal-title":"Cell Death Dis"},{"key":"4030_CR21","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.32604\/or.2024.043423","volume":"32","author":"W Jiang","year":"2024","unstructured":"Jiang W, Zhou M (2024) Analysis of the role of dihydromyricetin derived from vine tea (Ampelopsis grossedentata) on multiple myeloma by activating STAT1\/RIG-I axis. Oncol Res 32:1359\u20131368. https:\/\/doi.org\/10.32604\/or.2024.043423","journal-title":"Oncol Res"},{"key":"4030_CR22","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.4161\/auto.20792","volume":"8","author":"DH Kessel","year":"2012","unstructured":"Kessel DH, Price M, Reiners JJ (2012) ATG7 deficiency suppresses apoptosis and cell death induced by lysosomal photodamage. Autophagy 8:1333\u20131341. https:\/\/doi.org\/10.4161\/auto.20792","journal-title":"Autophagy"},{"key":"4030_CR23","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.7150\/thno.40919","volume":"10","author":"R Li","year":"2020","unstructured":"Li R, Li D, Wu C et al (2020) Nerve growth factor activates autophagy in Schwann cells to enhance myelin debris clearance and to expedite nerve regeneration. Theranostics 10:1649\u20131677. https:\/\/doi.org\/10.7150\/thno.40919","journal-title":"Theranostics"},{"key":"4030_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2023.154997","volume":"119","author":"X-J Li","year":"2023","unstructured":"Li X-J, Pang C, Peng Z et al (2023) Dihydromyricetin confers cerebroprotection against subarachnoid hemorrhage via the Nrf2-dependent Prx2 signaling cascade. Phytomedicine 119:154997. https:\/\/doi.org\/10.1016\/j.phymed.2023.154997","journal-title":"Phytomedicine"},{"key":"4030_CR25","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1093\/abbs\/gmy003","volume":"50","author":"H Ling","year":"2018","unstructured":"Ling H, Zhu Z, Yang J et al (2018) Dihydromyricetin improves type 2 diabetes-induced cognitive impairment via suppressing oxidative stress and enhancing brain-derived neurotrophic factor-mediated neuroprotection in mice. Acta Biochim Biophys Sin 50:298\u2013306. https:\/\/doi.org\/10.1093\/abbs\/gmy003","journal-title":"Acta Biochim Biophys Sin"},{"key":"4030_CR26","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1111\/jcmm.13403","volume":"22","author":"L Liu","year":"2018","unstructured":"Liu L, Zhou M, Lang H et al (2018) Dihydromyricetin enhances glucose uptake by inhibition of MEK\/ERK pathway and consequent down-regulation of phosphorylation of PPAR\u03b3 in 3T3-L1 cells. J Cell Mol Med 22:1247\u20131256. https:\/\/doi.org\/10.1111\/jcmm.13403","journal-title":"J Cell Mol Med"},{"key":"4030_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2023.154756","volume":"115","author":"X Liu","year":"2023","unstructured":"Liu X, Li Y, Chen S et al (2023) Dihydromyricetin attenuates intracerebral hemorrhage by reversing the effect of LCN2 via the system Xc- pathway. Phytomedicine 115:154756. https:\/\/doi.org\/10.1016\/j.phymed.2023.154756","journal-title":"Phytomedicine"},{"key":"4030_CR28","doi-asserted-by":"publisher","first-page":"14727","DOI":"10.1021\/acs.jafc.4c02379","volume":"72","author":"R Liu","year":"2024","unstructured":"Liu R, Jiang L, Chen Y et al (2024) Ginsenoside-Rh2 promotes functional recovery after spinal cord injury by enhancing TFEB-mediated autophagy. J Agric Food Chem 72:14727\u201314746. https:\/\/doi.org\/10.1021\/acs.jafc.4c02379","journal-title":"J Agric Food Chem"},{"key":"4030_CR29","doi-asserted-by":"publisher","first-page":"6242","DOI":"10.3748\/wjg.v23.i34.6242","volume":"23","author":"C-J Lu","year":"2017","unstructured":"Lu C-J, He Y-F, Yuan W-Z et al (2017) Dihydromyricetin-mediated inhibition of the Notch1 pathway induces apoptosis in QGY7701 and HepG2 hepatoma cells. World J Gastroenterol 23:6242\u20136251. https:\/\/doi.org\/10.3748\/wjg.v23.i34.6242","journal-title":"World J Gastroenterol"},{"key":"4030_CR30","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1007\/s10495-017-1381-3","volume":"22","author":"Y Luo","year":"2017","unstructured":"Luo Y, Lu S, Dong X et al (2017) Dihydromyricetin protects human umbilical vein endothelial cells from injury through ERK and Akt mediated Nrf2\/HO-1 signaling pathway. Apoptosis 22:1013\u20131024. https:\/\/doi.org\/10.1007\/s10495-017-1381-3","journal-title":"Apoptosis"},{"key":"4030_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2022.113752","volume":"155","author":"AI Matouk","year":"2022","unstructured":"Matouk AI, Awad EM, El-Tahawy NFG et al (2022) Dihydromyricetin alleviates methotrexate-induced hepatotoxicity via suppressing the TLR4\/NF-\u03baB pathway and NLRP3 inflammasome\/caspase 1 axis. Biomed Pharmacother 155:113752. https:\/\/doi.org\/10.1016\/j.biopha.2022.113752","journal-title":"Biomed Pharmacother"},{"key":"4030_CR32","doi-asserted-by":"publisher","first-page":"3312","DOI":"10.1038\/s41467-018-05862-6","volume":"9","author":"G Napolitano","year":"2018","unstructured":"Napolitano G, Esposito A, Choi H et al (2018) mTOR-dependent phosphorylation controls TFEB nuclear export. Nat Commun 9:3312. https:\/\/doi.org\/10.1038\/s41467-018-05862-6","journal-title":"Nat Commun"},{"key":"4030_CR33","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1096\/fj.07-9574LSF","volume":"22","author":"S Reagan-Shaw","year":"2008","unstructured":"Reagan-Shaw S, Nihal M, Ahmad N (2008) Dose translation from animal to human studies revisited. FASEB J off Publ Fed Am Soc Exp Biol 22:659\u2013661. https:\/\/doi.org\/10.1096\/fj.07-9574LSF","journal-title":"FASEB J off Publ Fed Am Soc Exp Biol"},{"key":"4030_CR34","doi-asserted-by":"publisher","first-page":"2487","DOI":"10.1056\/NEJMoa043445","volume":"352","author":"PG Richardson","year":"2005","unstructured":"Richardson PG, Sonneveld P, Schuster MW et al (2005) Bortezomib or high-dose dexamethasone for relapsed multiple myeloma. N Engl J Med 352:2487\u20132498. https:\/\/doi.org\/10.1056\/NEJMoa043445","journal-title":"N Engl J Med"},{"key":"4030_CR35","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1146\/annurev.med.57.042905.122625","volume":"57","author":"PG Richardson","year":"2006","unstructured":"Richardson PG, Mitsiades C, Hideshima T, Anderson KC (2006) Bortezomib: proteasome inhibition as an effective anticancer therapy. Annu Rev Med 57:33\u201347. https:\/\/doi.org\/10.1146\/annurev.med.57.042905.122625","journal-title":"Annu Rev Med"},{"key":"4030_CR36","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1126\/science.1204592","volume":"332","author":"C Settembre","year":"2011","unstructured":"Settembre C, Di Malta C, Polito VA et al (2011) TFEB links autophagy to lysosomal biogenesis. Science 332:1429\u20131433. https:\/\/doi.org\/10.1126\/science.1204592","journal-title":"Science"},{"key":"4030_CR37","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.1002\/glia.21065","volume":"58","author":"YK Shin","year":"2010","unstructured":"Shin YK, Jang SY, Lee HK et al (2010) Pathological adaptive responses of Schwann cells to endoplasmic reticulum stress in bortezomib-induced peripheral neuropathy. Glia 58:1961\u20131976. https:\/\/doi.org\/10.1002\/glia.21065","journal-title":"Glia"},{"key":"4030_CR38","doi-asserted-by":"publisher","first-page":"4245","DOI":"10.7150\/jca.32807","volume":"10","author":"M Tan","year":"2019","unstructured":"Tan M, Jiang B, Wang H et al (2019) Dihydromyricetin induced lncRNA MALAT1-TFEB-dependent autophagic cell death in cutaneous squamous cell carcinoma. J Cancer 10:4245\u20134255. https:\/\/doi.org\/10.7150\/jca.32807","journal-title":"J Cancer"},{"key":"4030_CR39","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1038\/s41418-022-01028-6","volume":"29","author":"A Tan","year":"2022","unstructured":"Tan A, Prasad R, Lee C, Jho E-H (2022) Past, present, and future perspectives of transcription factor EB (TFEB): mechanisms of regulation and association with disease. Cell Death Differ 29:1433\u20131449. https:\/\/doi.org\/10.1038\/s41418-022-01028-6","journal-title":"Cell Death Differ"},{"key":"4030_CR40","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1097\/CND.0000000000000077","volume":"16","author":"SP Thawani","year":"2015","unstructured":"Thawani SP, Tanji K, De Sousa EA et al (2015) Bortezomib-associated demyelinating neuropathy\u2013clinical and pathologic features. J Clin Neuromuscul Dis 16:202\u2013209. https:\/\/doi.org\/10.1097\/CND.0000000000000077","journal-title":"J Clin Neuromuscul Dis"},{"key":"4030_CR41","doi-asserted-by":"publisher","first-page":"e00489","DOI":"10.1128\/MCB.00489-18","volume":"39","author":"J Tsalikis","year":"2019","unstructured":"Tsalikis J, Abdel-Nour M, Farahvash A et al (2019) Isoginkgetin, a natural biflavonoid proteasome inhibitor, sensitizes cancer cells to apoptosis via disruption of lysosomal homeostasis and impaired protein clearance. Mol Cell Biol 39:e00489-e518. https:\/\/doi.org\/10.1128\/MCB.00489-18","journal-title":"Mol Cell Biol"},{"key":"4030_CR42","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1080\/15548627.2016.1271514","volume":"13","author":"S Vega-Rubin-de-Celis","year":"2017","unstructured":"Vega-Rubin-de-Celis S, Pe\u00f1a-Llopis S, Konda M, Brugarolas J (2017) Multistep regulation of TFEB by MTORC1. Autophagy 13:464\u2013472. https:\/\/doi.org\/10.1080\/15548627.2016.1271514","journal-title":"Autophagy"},{"issue":"Suppl 2","key":"4030_CR43","doi-asserted-by":"publisher","first-page":"S52","DOI":"10.1111\/jns.12338","volume":"24","author":"R Velasco","year":"2019","unstructured":"Velasco R, Alberti P, Bruna J et al (2019) Bortezomib and other proteosome inhibitors-induced peripheral neurotoxicity: from pathogenesis to treatment. J Peripher Nerv Syst JPNS 24(Suppl 2):S52\u2013S62. https:\/\/doi.org\/10.1111\/jns.12338","journal-title":"J Peripher Nerv Syst JPNS"},{"key":"4030_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2020.153414","volume":"82","author":"Z Wang","year":"2021","unstructured":"Wang Z, Sun X, Feng Y et al (2021) Dihydromyricetin reverses MRP2-induced multidrug resistance by preventing NF-\u03baB-Nrf2 signaling in colorectal cancer cell. Phytomedicine 82:153414. https:\/\/doi.org\/10.1016\/j.phymed.2020.153414","journal-title":"Phytomedicine"},{"key":"4030_CR45","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1186\/s12974-023-02931-6","volume":"20","author":"X Wang","year":"2023","unstructured":"Wang X, Xie Y, Chen G et al (2023) Intermittent hypoxia therapy ameliorates beta-amyloid pathology via TFEB-mediated autophagy in murine Alzheimer\u2019s disease. J Neuroinflammation 20:240. https:\/\/doi.org\/10.1186\/s12974-023-02931-6","journal-title":"J Neuroinflammation"},{"key":"4030_CR46","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1038\/sj.bjc.6605954","volume":"103","author":"T Watanabe","year":"2010","unstructured":"Watanabe T, Nagase K, Chosa M, Tobinai K (2010) Schwann cell autophagy induced by SAHA, 17-AAG, or clonazepam can reduce bortezomib-induced peripheral neuropathy. Br J Cancer 103:1580\u20131587. https:\/\/doi.org\/10.1038\/sj.bjc.6605954","journal-title":"Br J Cancer"},{"key":"4030_CR47","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s40035-019-0159-7","volume":"8","author":"J-Z Wu","year":"2019","unstructured":"Wu J-Z, Ardah M, Haikal C et al (2019) Dihydromyricetin and Salvianolic acid B inhibit alpha-synuclein aggregation and enhance chaperone-mediated autophagy. Transl Neurodegener 8:18. https:\/\/doi.org\/10.1186\/s40035-019-0159-7","journal-title":"Transl Neurodegener"},{"key":"4030_CR48","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1007\/s00204-023-03468-6","volume":"97","author":"Z Wu","year":"2023","unstructured":"Wu Z, Yan W, Wang K et al (2023) Lysosomal dysfunction in Schwann cells is involved in bortezomib-induced peripheral neurotoxicity. Arch Toxicol 97:1385\u20131396. https:\/\/doi.org\/10.1007\/s00204-023-03468-6","journal-title":"Arch Toxicol"},{"key":"4030_CR49","doi-asserted-by":"publisher","first-page":"82","DOI":"10.3892\/br.2024.1769","volume":"20","author":"T Xia","year":"2024","unstructured":"Xia T, Zhu R (2024) Multiple molecular and cellular mechanisms of the antitumour effect of dihydromyricetin (Review). Biomed Rep 20:82. https:\/\/doi.org\/10.3892\/br.2024.1769","journal-title":"Biomed Rep"},{"key":"4030_CR50","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.fct.2014.01.014","volume":"66","author":"J Xia","year":"2014","unstructured":"Xia J, Guo S, Fang T et al (2014) Dihydromyricetin induces autophagy in HepG2 cells involved in inhibition of mTOR and regulating its upstream pathways. Food Chem Toxicol 66:7\u201313. https:\/\/doi.org\/10.1016\/j.fct.2014.01.014","journal-title":"Food Chem Toxicol"},{"key":"4030_CR51","doi-asserted-by":"publisher","first-page":"3071","DOI":"10.2147\/DDDT.S378786","volume":"16","author":"J Xie","year":"2022","unstructured":"Xie J, Zhang T, Li P et al (2022) Dihydromyricetin attenuates cerebral ischemia reperfusion injury by inhibiting SPHK1\/mTOR signaling and targeting ferroptosis. Drug des Devel Ther 16:3071\u20133085. https:\/\/doi.org\/10.2147\/DDDT.S378786","journal-title":"Drug des Devel Ther"},{"key":"4030_CR52","doi-asserted-by":"publisher","first-page":"2547","DOI":"10.1080\/15548627.2022.2039535","volume":"18","author":"J Xu","year":"2022","unstructured":"Xu J, Yang KC, Go NE et al (2022) Chloroquine treatment induces secretion of autophagy-related proteins and inclusion of Atg8-family proteins in distinct extracellular vesicle populations. Autophagy 18:2547\u20132560. https:\/\/doi.org\/10.1080\/15548627.2022.2039535","journal-title":"Autophagy"},{"key":"4030_CR53","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2021.112068","volume":"142","author":"W Yan","year":"2021","unstructured":"Yan W, Wu Z, Zhang Y et al (2021) The molecular and cellular insight into the toxicology of bortezomib-induced peripheral neuropathy. Biomed Pharmacother 142:112068. https:\/\/doi.org\/10.1016\/j.biopha.2021.112068","journal-title":"Biomed Pharmacother"},{"key":"4030_CR54","doi-asserted-by":"publisher","first-page":"10082","DOI":"10.3748\/wjg.v20.i29.10082","volume":"20","author":"Q-Y Zhang","year":"2014","unstructured":"Zhang Q-Y, Li R, Zeng G-F et al (2014) Dihydromyricetin inhibits migration and invasion of hepatoma cells through regulation of MMP-9 expression. World J Gastroenterol 20:10082\u201310093. https:\/\/doi.org\/10.3748\/wjg.v20.i29.10082","journal-title":"World J Gastroenterol"},{"key":"4030_CR55","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.21037\/atm-20-5838","volume":"8","author":"W Zhang","year":"2020","unstructured":"Zhang W, Yang L, Li L, Feng W (2020) Dihydromyricetin attenuates neuropathic pain via enhancing the transition from M1 to M2 phenotype polarization by potentially elevating ALDH2 activity in vitro and vivo. Ann Transl Med 8:1151. https:\/\/doi.org\/10.21037\/atm-20-5838","journal-title":"Ann Transl Med"},{"key":"4030_CR56","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1080\/15548627.2019.1688488","volume":"16","author":"Z Zhang","year":"2020","unstructured":"Zhang Z, Yan J, Bowman AB et al (2020b) Dysregulation of TFEB contributes to manganese-induced autophagic failure and mitochondrial dysfunction in astrocytes. Autophagy 16:1506\u20131523. https:\/\/doi.org\/10.1080\/15548627.2019.1688488","journal-title":"Autophagy"},{"key":"4030_CR57","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2024.107455","volume":"138","author":"R Zhang","year":"2024","unstructured":"Zhang R, Yang X, Shi X et al (2024) Bortezomib modulated the autophagy-lysosomal pathway in a TFEB-dependent manner in multiple myeloma. Leuk Res 138:107455. https:\/\/doi.org\/10.1016\/j.leukres.2024.107455","journal-title":"Leuk Res"},{"key":"4030_CR58","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1248\/bpb.b22-00668","volume":"46","author":"Z Zhou","year":"2023","unstructured":"Zhou Z, Nagayasu K, Shirakawa H, Kaneko S (2023) Specific cellular effects of low bortezomib concentrations on purified cultures of schwann cells, satellite glial cells, macrophages, and dorsal root ganglion neurons. Biol Pharm Bull 46:102\u2013110. https:\/\/doi.org\/10.1248\/bpb.b22-00668","journal-title":"Biol Pharm Bull"}],"container-title":["Archives of Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-025-04030-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00204-025-04030-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-025-04030-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T11:35:56Z","timestamp":1758540956000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00204-025-04030-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,6]]},"references-count":58,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["4030"],"URL":"https:\/\/doi.org\/10.1007\/s00204-025-04030-2","relation":{},"ISSN":["0340-5761","1432-0738"],"issn-type":[{"value":"0340-5761","type":"print"},{"value":"1432-0738","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,6]]},"assertion":[{"value":"5 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures were performed in accordance with the guidelines of the Zhejiang University Animal Experimentation Committee and were in complete compliance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}